IV. To compare the rate of pathologic complete response (nodes and tumor). V. To compare the rate of clinical complete response rate (cCR). VI. To compare the rate of negative circumferential margin. VII. To compare the rate of completion of all cycles of neoadjuvant chemotherapy.